HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhifeng Wei Selected Research

madecassoside

12/2020Regulation of gut microbiota substantially contributes to the induction of intestinal Treg cells and consequent anti-arthritis effect of madecassoside.
1/2017Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway.
3/2015Intestinal interleukin-10 mobilization as a contributor to the anti-arthritis effect of orally administered madecassoside: a unique action mode of saponin compounds with poor bioavailability.
8/2012Madecassoside suppresses migration of fibroblasts from keloids: involvement of p38 kinase and PI3K signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhifeng Wei Research Topics

Disease

14Experimental Arthritis
01/2022 - 08/2012
14Arthritis (Polyarthritis)
10/2021 - 08/2012
13Colitis
07/2022 - 12/2014
8Rheumatoid Arthritis
10/2021 - 08/2012
6Neoplasms (Cancer)
01/2022 - 06/2010
6Inflammation (Inflammations)
01/2021 - 08/2012
4Hypoxia (Hypoxemia)
01/2022 - 04/2016
3Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2017
3Carcinoma (Carcinomatosis)
05/2018 - 08/2012
3Urinary Bladder Neoplasms (Bladder Cancer)
05/2018 - 06/2010
2Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022 - 01/2018
2Colitis-Associated Neoplasms
01/2022 - 10/2020
2Acute Lung Injury
07/2012 - 10/2011
1Asthma (Bronchial Asthma)
01/2021
1Carcinogenesis
10/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020
1Diabetic Nephropathies (Diabetic Nephropathy)
12/2019
1Fibrosis (Cirrhosis)
01/2018
1Ulcerative Colitis
01/2018
1Triple Negative Breast Neoplasms
04/2016
1Neoplasm Metastasis (Metastasis)
04/2016
1Arthralgia (Joint Pain)
02/2016
1Shock
12/2015
1Septic Shock (Toxic Shock Syndrome)
12/2015

Drug/Important Bio-Agent (IBA)

8Dextran SulfateIBA
07/2022 - 12/2014
5tetrandrineIBA
01/2022 - 02/2016
5norisoboldineIBA
01/2022 - 08/2012
5TriterpenesIBA
01/2022 - 08/2012
5AlkaloidsIBA
01/2022 - 08/2012
4morinIBA
01/2022 - 12/2015
42-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amideIBA
01/2021 - 01/2018
4madecassosideIBA
12/2020 - 08/2012
4arctigeninIBA
10/2020 - 12/2014
3Interleukin-17 (Interleukin 17)IBA
01/2022 - 01/2017
3madecassic acidIBA
01/2022 - 01/2017
3LipopolysaccharidesIBA
01/2021 - 10/2011
3BerberineIBA
11/2019 - 01/2017
3CollagenIBA
01/2018 - 08/2012
3Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2018 - 02/2016
3Interleukin-10 (Interleukin 10)IBA
01/2017 - 03/2015
3CytokinesIBA
02/2016 - 03/2015
3Interleukin-6 (Interleukin 6)IBA
12/2015 - 08/2012
3ScopoletinIBA
07/2015 - 12/2012
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2022 - 01/2018
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 01/2018
2Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 10/2020
2Pharmaceutical PreparationsIBA
10/2021 - 01/2021
216S Ribosomal RNAIBA
12/2020 - 11/2019
2Butyrates (Butyrate)IBA
12/2020 - 11/2019
2alpinetinIBA
12/2019 - 01/2018
2CurcuminIBA
01/2018 - 05/2015
2MicroRNAs (MicroRNA)IBA
01/2018 - 08/2012
2Proteins (Proteins, Gene)FDA Link
12/2016 - 07/2014
2SaponinsIBA
03/2015 - 08/2012
2Biological ProductsIBA
07/2014 - 05/2013
1Acetyl Coenzyme A (Acetyl-CoA)IBA
01/2022
1Polysaccharides (Glycans)IBA
01/2022
1EnzymesIBA
01/2022
1alpha-hydroxyglutarateIBA
01/2022
1epacadostatIBA
12/2021
1IsoenzymesIBA
12/2021
1Platelet-Derived Growth FactorIBA
10/2021
1Mechanistic Target of Rapamycin Complex 2IBA
10/2021
1Diclofenac (SR 38)FDA LinkGeneric
10/2021
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2021
1Dextrans (Dextran)FDA Link
01/2021
1OccludinIBA
01/2021
1Coenzyme A (CoA)IBA
12/2020
1Butyric Acid (Butanoic Acid)IBA
12/2020
1Anti-Bacterial Agents (Antibiotics)IBA
12/2020
1AzoxymethaneIBA
10/2020
1InflammasomesIBA
10/2020
1Leucine (L-Leucine)FDA Link
12/2019
1bergeninIBA
12/2019
1NitratesIBA
11/2019
1FlavonoidsIBA
11/2018
1SurvivinIBA
05/2018
1EmulsionsIBA
01/2018
1Freund's AdjuvantIBA
01/2018
1Syk KinaseIBA
01/2018
1Sirtuin 1IBA
01/2018
1BenzylisoquinolinesIBA
01/2018
1NAD (NADH)IBA
01/2018
1isoquinolineIBA
01/2017
1GhrelinIBA
01/2017
1Ghrelin ReceptorsIBA
01/2017
1Interleukin-22 (IL-22)IBA
01/2017
1cortistatinIBA
01/2017
1interleukin-21 (interleukin 21)IBA
01/2017
1Mechanistic Target of Rapamycin Complex 1IBA
12/2016
1escin IaIBA
04/2016
1Neutralizing AntibodiesIBA
12/2015
1ammonium trichloro(dioxoethylene-O,O'-)tellurate (AS 101)IBA
12/2015
1EstersIBA
12/2015

Therapy/Procedure

8Oral Administration
01/2022 - 03/2015
3Therapeutics
05/2015 - 08/2012
1Intraperitoneal Injections
07/2022
1Immunotherapy
12/2021
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2020
1Intravenous Injections
01/2017